2-131478155-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_080386.4(TUBA3D):c.4-9T>G variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00216 in 1,609,860 control chromosomes in the GnomAD database, including 73 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.013 ( 40 hom., cov: 33)
Exomes 𝑓: 0.0010 ( 33 hom. )
Consequence
TUBA3D
NM_080386.4 splice_polypyrimidine_tract, intron
NM_080386.4 splice_polypyrimidine_tract, intron
Scores
2
Splicing: ADA: 0.006317
2
Clinical Significance
Conservation
PhyloP100: -0.340
Genes affected
TUBA3D (HGNC:24071): (tubulin alpha 3d) This gene encodes a member of the alpha tubulin family. Tubulin is a major component of microtubules, which are composed of alpha- and beta-tubulin heterodimers and microtubule-associated proteins in the cytoskeleton. Microtubules maintain cellular structure, function in intracellular transport, and play a role in spindle formation during mitosis. [provided by RefSeq, Oct 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 2-131478155-T-G is Benign according to our data. Variant chr2-131478155-T-G is described in ClinVar as [Likely_benign]. Clinvar id is 788512.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0129 (1965/152362) while in subpopulation AFR AF= 0.0434 (1804/41570). AF 95% confidence interval is 0.0417. There are 40 homozygotes in gnomad4. There are 931 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1965 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TUBA3D | NM_080386.4 | c.4-9T>G | splice_polypyrimidine_tract_variant, intron_variant | ENST00000321253.7 | |||
MZT2A | XM_005263742.4 | c.320-5973A>C | intron_variant | ||||
MZT2A | XM_047445568.1 | c.623-5973A>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TUBA3D | ENST00000321253.7 | c.4-9T>G | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_080386.4 | P1 | |||
MZT2A | ENST00000427024.5 | c.279-5973A>C | intron_variant, NMD_transcript_variant | 3 | |||||
MZT2A | ENST00000445782.2 | n.331-5973A>C | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0128 AC: 1955AN: 152248Hom.: 40 Cov.: 33
GnomAD3 genomes
AF:
AC:
1955
AN:
152248
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00176 AC: 440AN: 249846Hom.: 12 AF XY: 0.00135 AC XY: 182AN XY: 135068
GnomAD3 exomes
AF:
AC:
440
AN:
249846
Hom.:
AF XY:
AC XY:
182
AN XY:
135068
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00104 AC: 1515AN: 1457498Hom.: 33 Cov.: 32 AF XY: 0.000917 AC XY: 664AN XY: 724400
GnomAD4 exome
AF:
AC:
1515
AN:
1457498
Hom.:
Cov.:
32
AF XY:
AC XY:
664
AN XY:
724400
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0129 AC: 1965AN: 152362Hom.: 40 Cov.: 33 AF XY: 0.0125 AC XY: 931AN XY: 74508
GnomAD4 genome
AF:
AC:
1965
AN:
152362
Hom.:
Cov.:
33
AF XY:
AC XY:
931
AN XY:
74508
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 29, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at